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Tonsillectomy, performed with or without adenoidectomy, is one of 
the most frequently performed surgical procedures in children.[1,2] 
In the USA, tonsillectomy accounts for one-third of the paediatric 
procedures performed under general anaesthesia.[3] It is, however, 
a procedure that lacks evidence of being clinically effective[4] and 
cost-effective.[5] It is interesting to note a steady decline in the 
US tonsillectomy rate in recent times,[1] as evidence in support of 
the procedure has been found to be equivocal. A similar trend is 
evident in the UK, with only a quarter the number of tonsillectomies 
performed in the modern era compared with the early 20th century.[6]
The two major indications for tonsillectomy are recurrent throat 
infections and sleep disordered breathing (SDB), both of which can 
impact significantly on general health and quality of life.[7] In the 1980s, 
80% of tonsillectomies were performed for infective indications i.e. 
recurrent tonsillitis or sore throat.[7] There has, however, been a shift 
in clinical practice in recent years. In 2011, 85% of tonsillectomies 
were performed for obstructive symptoms i.e. SDB.[8] Despite well-
established, evidence-based guidelines having been published by 
various groups (Table 1), the indications for tonsillectomy remain 
controversial and have been a source of much debate among the role 
players managing these patients.[9] It is surprising to note, therefore, 
that for such a common procedure with internationally recognised 
and standardised indications, there exists significant international 
variation in tonsillectomy rates. Furthermore, tonsillectomy rates 
show considerable regional/geographical variation within the same 
country. This variation has been ascribed to differences in clinical 
practice and referral patterns, as well as social[10] and family factors,[11] 
rather than differences in clinical need or regional morbidity.[12-14]
Between 2000 and 2005, Suleman et al.[15] reported a national 
annual tonsillectomy rate of 304/100 000 children <15 years of age 
for the National Health Service (NHS) in England. Interestingly, 
tonsillectomy rates varied sevenfold across local authority areas. This 
substantial variation was even greater when tonsillectomy data from 
the independent healthcare sector (representing 15% of ear, nose 
and throat activity in the UK) were factored into the calculations. 
In Scotland in 1992, regional tonsillectomy rates showed a threefold 
variation.[16] 
In the USA, Boss et al.[1] described a tonsillectomy rate of 
791/100 000 children ≤19 years of age in 2012, with a fourfold 
regional variation in rate. Tonsillectomy rates in children insured by 
the state-funded Medicaid programme in the USA were similar to 
those insured by private sources.
In Germany, the annual average adeno-/tonsillectomy rate between 
2007 and 2010 was reported as 480/100 000 for children and 
adolescents ≤19 years of age.[17] The tonsillectomy rate varied up to 
threefold among German federal states. There was an even greater 
variation when tonsillectomy rates were analysed at a district level, 
with rates in some districts up to eight times higher than in other 
districts.
The lowest national tonsillectomy rate reported in the literature 
is that of Canada, with a rate of 190/100 000 children ≤19 years of 
age. Northern Ireland has the highest reported rate, 850/100 000. 
Other countries for which the national tonsillectomy rate has been 
calculated include Finland (605/100 000), Australia (620/100 000), 
Belgium (685/100 000) and the Netherlands (790/100 000).[18]
The South African (SA) adeno-/tonsillectomy rate has never 
been described before. It has therefore been difficult to compare 
local practice with international norms. Describing the adeno-/
tonsillectomy rate is a daunting task because of the complexity of 
the SA healthcare system, which comprises both public and private 
sectors. In 2013, the private healthcare sector catered for the 18% 
of the population (9.7 million people)[19] who could afford the 
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monthly premiums or those who were willing to pay a fee for private 
healthcare. This audit focused on the private healthcare sector and 
excluded the resource-constrained public healthcare sector, as adeno-/
tonsillectomy in the state sector is generally reserved for children with 
severe SDB, owing to poor access to healthcare and specialist services. 
The public sector serves 82% of the population (43.4 million people) 
and is heavily burdened, with facilities overcrowded, underfunded 
and understaffed. Uninsured SA patients therefore have limited 
access to tonsillectomy at state hospitals, where the indications for 
such surgical procedures are often modified to be locally relevant and 
ensure sustainable service provision.
It has long been accepted that tonsillectomy in children suffering 
from recurrent throat infections improves quality of life, reduces 
the number of visits to healthcare providers and reduces antibiotic 
use. [20] However, evidence supporting surgery for infective/sore 
throat indications is equivocal. Most trials investigating efficacy of 
the procedure[21-23] display bias due to poorly defined entrance criteria, 
non-randomised selection of cases, exclusion of the most severely 
affected patients and reliance on caregivers for data collection. In 
a 2014 Cochrane review[4] assessing the effectiveness of adeno-/
tonsillectomy in reducing the frequency and severity of sore throat in 
patients with chronic or recurrent acute tonsillitis, benefit was shown 
to be modest at best. When compared with non-surgical management, 
operated patients experienced only 1.4 fewer episodes of sore throat 
in the first year postoperatively, at the cost of one sore throat as a 
consequence of surgery. It was also noted that children with the most 
severe symptoms were most likely to experience benefit from surgical 
management and that some children’s symptoms resolved without any 
Table 1. Indications for adeno-/tonsillectomy[18,21,24]
Paradise criteria
Scottish Intercollegiate 
Guideline 
American Academy of Otolaryngo-
logy - Head and Neck Surgery
Frequency of throat 
infections
≥7 in preceding year
OR
≥5 per year in preceding 2 years
OR
≥3 per year in preceding 3 years
≥7 in preceding year
OR
≥5 per year in preceding 2 years
OR
≥3 per year in preceding 3 years
≥7 in preceding year
OR
≥5 per year in preceding 2 years
OR
≥3 per year in preceding 3 years
Clinical features In addition to sore throat, one or 
more of the following:
Temperature >38.3 °C
OR
Cervical lymphadenopathy 
(tender or >2 cm)
OR
Tonsillar exudate
OR
Culture positive for group A 
β-haemolytic streptococcus
In addition to sore throat, one or more 
of the following:
Temperature >38.3°C
OR
Cervical lymphadenopathy (tender or 
>2 cm)
OR
Tonsillar exudate
OR
Culture positive for group A 
β-haemolytic streptococcus
Modifying factors:
Favouring tonsillectomy if 
frequency criteria not met
Multiple antibiotic allergy/intolerance
History of peritonsillar abscess
PFAPA (periodic fever,
aphthous stomatitis,
pharyngitis and adenitis)
Antibiotics Administered in conventional 
dose for suspected/proven 
streptococcal episodes
Documentation Each episode and associated 
clinical features recorded
Episodes should be well 
documented
Each episode and associated clinical 
and social features recorded
SDB/
polysomnography
Counsel caregivers about 
tonsillectomy as a means to improve 
health in children with abnormal 
polysomnography
Ask about comorbid conditions that 
might improve with tonsillectomy: 
growth retardation, poor school 
performance, enuresis, behavioural 
problems
Watchful waiting Observe for 12 months, owing to 
tendency of throat infections to 
improve over time
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surgery. No firm conclusions could be reached on the effectiveness 
of surgical as opposed to non-surgical management as there was 
insufficient information available.
Adeno-/tonsillectomy is, therefore, a procedure in search of 
evidence.
Objectives
The SA tonsillectomy rate has, to the authors’ knowledge, never 
been reported. This audit set out to describe the tonsillectomy rate 
in the SA private healthcare sector, which compares favourably 
with health systems in the developed world and countries in which 
tonsillectomy rates have been reported. The objective was to define 
both national and regional adeno-/tonsillectomy rates. Determining 
the tonsillectomy rate in the SA private healthcare sector would 
provide a tool enabling comparisons of SA practice with international 
trends. It would also aid in justifying recommendations regarding 
the modification of local tonsillectomy indications, to align SA 
practice with internationally accepted norms. This audit also set out 
to identify and comment on trends in clinical practice with regard to 
adeno-/tonsillectomy in the SA private healthcare sector.
Methods
A retrospective review of the 2012 and 2013 adeno-/tonsillectomy 
data from Discovery Health Medical Scheme, SA’s largest private 
healthcare insurer, was performed. Of the 18% (9.7 million people) 
of South Africans with private medical insurance, Discovery Health 
Medical Scheme accounts for a 30% (approximately 2.7 million 
people) market share. Of this sample, 771 720 people in 2012 
and 797 310 people in 2013 were 19 years of age or younger. This 
cohort comprised the study population. This correlates with most 
international studies, where the national tonsillectomy rate has 
been calculated for this age group. Using STATA 12.0 (StataCorp, 
USA) data analysis and statistical software, we calculated the SA 
tonsillectomy rate per 100 000 people ≤19 years of age and compared 
this rate with international rates reported in the literature. The 
regional tonsillectomy rate was also calculated for 16 geographical 
regions defined by Discovery Health. The 95% confidence intervals 
(CIs) were calculated for both the national and regional tonsillectomy 
rates. We also calculated the percentage of adeno-/tonsillectomies 
performed by ear, nose and throat (ENT) surgeons and the percentage 
performed by GPs, as well as the ENT surgeon-to-patient ratio, both 
nationally and regionally.
Adeno-/tonsillectomy data for the same period were also sourced 
from Bonitas Medical Fund, another of SA’s large private medical aid 
providers. Bonitas insures 7% of privately insured South Africans, 
roughly 650 000 people in 2013. Of this sample, 204 842 people in 
2012 and 228 429 people in 2013 were 19 years of age or younger. 
The national adeno-/tonsillectomy rate within the Bonitas-insured 
population was calculated and compared with the Discovery Medical 
Scheme rate.
Results
Within the Discovery Health Medical Scheme cohort, a total of 
14 574 and 13 989 adeno-/tonsillectomies were performed in 2012 
and 2013, respectively. The SA private healthcare sector adeno-/
tonsillectomy rate in 2012 was 1 888/100 000 people ≤19 years of age. 
The rate dropped significantly to 1 755/100 000 in 2013 (p<0.001). 
Both are more than double the highest tonsillectomy rate reported 
in the literature. There was also considerable regional variation in 
the adeno-/tonsillectomy rate within SA (p=0.046; pooled 2-year 
data). In 2012 and 2013, the highest regional rate was observed 
in the West Coast/Karoo/Cape Town Northern Suburbs region: 
2 754/100 000 and 2 507/100 000 people ≤19 years of age, respec tively. 
The lowest adeno-tonsillectomy rate was reported in Polokwane in 
2012 (1 307/100 000) and East London in 2013 (1 445/100 000). 
From 2012 to 2013, four regions demonstrated an increase in adeno-/
tonsillectomy rate: the Overberg, the Garden Route, East London and 
Polokwane. This goes against the national reduction in rate observed 
over the same period. Results are summarised in Table 2.
GPs performed 2 726 of the 13 989 adeno-/tonsillectomies in 2013, 
i.e. about 20%. Otorhinolaryngologists operated on the remaining 
11 263 patients, i.e. 80% of adeno-/tonsillectomies performed in 
Table 2. Regional variation in the SA adeno-/tonsillectomy rate/100 000 for Discovery-insured population ≤19 years of age
Region
Tonsillectomy rate
2012 (95% CI)
Tonsillectomy rate
2013 (95% CI)
Average rates
2012/2013
Polokwane 1 307 (1 123 - 1 513) 1 473 (1 281 - 1 688) 1 390
East London 1 400 (1 220 - 1 597) 1 445 (1 265 - 1 642) 1 423
Durban 1 516 (1 439 -1 596) 1 459 (1 384 - 1 535) 1 488
Port Elizabeth 1 569 (1 411 - 1 739) 1 468 (1 316 - 1 632) 1 519
Johannesburg 1 668 (1 620 - 1 717) 1 530 (1 485 - 1 577) 1 599
Cape Town Peninsula 1 694 (1 579 - 1 815) 1 592 (1 482 - 1 708) 1 643
Pietermaritzburg 1 822 (1 626 - 2 037) 1 555 (1 375 - 1 752) 1 689
Nelspruit 1 794 (1 558 - 2 055) 1 659 (1 434 - 1 908) 1 727
Rustenburg 1 902 (1 668 - 2 160) 1 701 (1 484 - 1 945) 1 802
Overberg 1 852 (1 634 - 2 091) 2 075 (1 848 - 2 323) 1 964
Pretoria 2 218 (2 132 - 2 305) 1 969 (1 890 - 2 045) 2 094
Vaal Triangle 2 250 (2 000 - 2 522) 2 241 (1 998 - 2 506) 2 246
Garden Route 2 198 (1 926 - 2 488) 2 348 (2 069 - 2 655) 2 273
Potchefstroom 2 460 (2 197 - 2 746) 2 268 (2 019 - 2 539) 2 364
Bloemfontein* 2 586 (2 402 - 2 781) 2 404 (2 230 - 2 589) 2 495
West Coast/Karoo† 2 753 (2 629 - 2 882) 2 507 (2 391 - 2 628) 2 630
SA overall‡ 1 888 (1 858 - 1 919) 1 755 (1 726 - 1 784) 1 820
* Includes Northern Cape.† Includes Cape Town Northern Suburbs.‡ Calculated on national data; not an average of regional rates.
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2013 were performed by ENT surgeons (p<0.001). The percentage of 
adeno-/tonsillectomies performed by otorhinolaryngologists varied 
widely from region to region. In the Overberg, otorhinolaryngologists 
performed more than 99% of procedures. However, in the Vaal 
triangle, otorhinolaryngologists performed only 28% of adeno-/
tonsillectomies.
There did not appear to be any correlation between regional 
tonsillectomy rate and proportion of tonsillectomies performed by 
otorhinolaryngologists as opposed to GPs. In the three regions with 
the highest adeno-/tonsillectomy rates, Potchefstroom, Bloemfontein 
and the West Coast/Karoo, otorhinolaryngologists performed 53%, 
75% and 91% of procedures, respectively. Similarly, in the three 
regions with the lowest adeno-/tonsillectomy rates, Polokwane, East 
London and Durban, otorhinolaryngologists performed 41%, 91% 
and 88% of procedures. As such, regional tonsillectomy rates seem to 
reflect local practice preferences, rather than surgeon qualification.
Also noted was that the ENT surgeon-to-patient (≤19 years 
of age) ratio ranged from  1:1 809 along the Garden Route, to 
1:4 889 in Johannesburg. Once again, there was poor correlation 
between regional ENT surgeon-to-patient ratio and regional adeno-/
tonsillectomy rate. In the three regions with the highest adeno-/
tonsillectomy rates, ENT surgeon-to-patient ratio ranged from 
1:2 666 in Bloemfontein (the fourth-lowest ratio in SA) to 1:4 424 
in Potchefstroom (the third-highest ratio in SA). These findings are 
summarised in Table 3.
The national adeno-/tonsillectomy rate calculated in the Bonitas-
insured population was 1 164/100 000 people ≤19 years of age in 2012 
(95% CI 1 118 - 1 212) and 1 166/100 000 in 2013 (95% CI 1 121 - 
1 211). This rate is lower than the rate calculated in the Discovery-
insured population, but still significantly higher than international 
norms. The finding of an elevated tonsillectomy rate in the SA private 
healthcare sector is therefore not limited to the Discovery-insured 
population, but reproducible by at least one other insurer, suggesting 
a market trend.
Discussion
The SA tonsillectomy rate in the private healthcare sector (Discovery 
Medical Scheme-insured population) is significantly higher than that 
reported in the literature in other countries. It is roughly 10 times 
the rate described in Canada and more than double the highest 
reported rate, that of Northern Ireland. This finding was not limited 
to a single medical aid provider. The Bonitas adeno-/tonsillectomy 
rate was roughly six times higher than the Canadian rate. There is 
also significant regional variation in the adeno-/tonsillectomy rates 
within SA.
These findings raise an important question: What causes 
international and regional variation in adeno-/tonsillectomy rates and 
why is the SA rate the highest in the literature? Contributing factors 
are discussed below.
1. Differences in training
Differences in postgraduate training of otorhinolaryngology 
registrars have been shown to influence surgical practice and 
regional tonsillectomy rates.[24] In addition, Bloor et al.[25] noted 
that the otorhinolaryngologist attitude towards tonsillectomy was 
partly responsible for regional variation. The Paradise criteria are 
applied at the authors’ institution. Allowance is, however, made 
for deviation from the guidelines at the clinician’s discretion, if 
it is deemed reasonable, rational and in the best interests of the 
patient. Similarly, all otorhinolaryngology training units in SA 
apply the Paradise Criteria, the guidelines devised by the Scottish 
Intercollegiate Guidelines Network (SIGN) or the American Academy 
of Otolaryngology - Head and Neck Surgery (AAO-HNS) Clinical 
Practice Guidelines, occasionally with minor variations thereof.
2. Lack of consensus among role players managing 
throat infections/SDB
Capper and Canter[26] found that among those managing tonsillitis and 
SDB, GPs, otorhinolaryngologists and paediatricians failed to agree on 
Table 3. Regional breakdown of the number of general practitioners and ENT surgeons performing adeno-/tonsillectomies in 2013, 
and the regional division of labour
Region
GPs performing adeno-/
tonsillectomy, n
ENT surgeons performing 
adeno-/tonsillectomy, n
ENT surgeon-to-patient 
ratio (≤19 years of age)
Percentage of adeno-/
tonsillectomies 
performed by ENT 
surgeon (%)
Bloemfontein* 51 11 1:2 666 75
Cape Town Peninsula 12 15 1:3 245 97
Durban 36 27 1:3 652 88
East London 5 5 1:3 240 91
Garden Route 6 6 1:1 809 91
Johannesburg 104 58 1:4 889 76
Nelspruit 3 3 1:3 919 96
Overberg 1 6 1:2 426 99
Pietermaritzburg 13 9 1:1 930 47
Polokwane 21 3 1:4 775 41
Port Elizabeth 23 7 1:3 309 53
Potchefstroom 34 3 1:4 424 53
Pretoria 97 41 1:2 919 88
Rustenburg 10 3 1:4 249 63
Vaal Triangle 31 5 1:2 749 28
West Coast/Karoo† 29 24 1:2 897 91
SA overall 476 226 1:3 528 80
* Includes Northern Cape.
† Including Cape Town Northern Suburbs.
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the diagnostic features of tonsillitis, pharyngitis and upper respiratory 
tract infections. There was also professional disagreement on the 
indications for tonsillectomy among the groups and a statistically 
significant difference in perceived benefit of the procedure and 
expectations regarding the postoperative improvement in symptoms 
(frequency of sore throats, irregular breathing, irritability and poor 
concentration). As ENT surgeons are unlikely to be managing 
patients suffering from acute episodes of throat infection/sore throat, 
they rely on primary healthcare providers/GPs to provide them 
with as much information as possible to make an evidence-based 
decision on whether adeno-/tonsillectomy is indicated and likely to 
be of benefit. This includes information such as frequency of throat 
infections, associated clinical factors and socioeconomic as well as 
family impact of the disease. Tucker[27] highlights that even among 
otorhinolaryngologists, there is disagreement about the significance 
of the signs and symptoms in children with recurrent tonsillitis. It 
therefore appears that there is no clear management protocol for 
children suffering from recurrent tonsillitis and SDB. This generalised 
lack of consensus is concerning and efficient patient care can only be 
provided if all role players, reliant on one another in managing these 
children, are in agreement.
3. Variation in the implementation of evidence-based 
guidelines
Although studies since the 1970s have defined a suitable candidate 
population, many clinicians are still uncertain as to the indications 
for tonsillectomy.[28] In certain instances, only 35% of patients 
undergoing adeno-/tonsillectomy have been shown to meet the 
published criteria.[29] Even more concerning is Marshall et al.’s[30] 
finding that only a quarter of patients undergoing tonsillectomy for 
recurrent throat infection met evidence-based criteria. Despite this, 
the Scottish tonsillectomy audit notes that between 63.3% and 89.8% 
of patients referred to ENT surgeons because of recurrent tonsillitis, 
sore throat or obstructive symptoms are booked for tonsillectomy 
on their first visit to an outpatient ENT clinic.[16] This suggests that 
ENT surgeons are generally liberal when promoting tonsillectomy as 
a therapeutic option and often forego a period of watchful waiting, 
despite the recommendation of the guidelines to observe patients for 
a period of at least 6 months. Evidence also points to the fact that 
surgeons are more likely to break existing guidelines in favour of 
performing surgery rather than withholding surgery.[31]
When tonsillectomy is considered for SDB, overnight poly-
somnography is the gold standard in confirming the diagnosis and 
making recommendations with regard to management. The American 
Academy of Paediatrics advises polysomnography in all children 
suspected of experiencing SDB, prior to surgical intervention.[32] 
Others feel that it is not necessary to request polysomnography this 
liberally, as it gives no insight into the effect of the sleep disorder 
on the patient’s general wellbeing. Otorhinolaryngologists request 
polysomnography in less than 10% of children undergoing adeno-/
tonsillectomy.[33]
Although protocol-driven healthcare has its place in modern 
medicine, the authors of this study agree that it is ill-advised to 
implement guidelines blindly, at the expense of doctor insight, 
acumen and experience. The other extreme would be to flout 
guidelines entirely and enable doctors to operate on patients at their 
discretion. Whether or not this could be regarded as reasonable 
practice is debatable and beyond the scope of this article.
4. Inconclusive evidence on the effectiveness and  
benefit of adeno-/tonsillectomy
In their landmark trials conducted in Pittsburgh in 1984 and 2002, 
Paradise et al.[21,23] set out to determine the efficacy of adeno-/
tonsillectomy in reducing the number and severity of subsequent throat 
infections. In their initial study, eligibility required children to satisfy 
the ‘Paradise criteria.’ They noted that tonsillectomy is efficacious in 
reducing the number and severity of throat infections for 2 years, 
and possibly a third year, following surgery. The study concluded 
that the degree of benefit experienced justified tonsillectomy in those 
meeting the strict inclusion criteria, but also emphasised that many 
children treated non-surgically improved spontaneously. The benefit 
seems modest as best. In the follow-up study, the Paradise criteria 
were relaxed somewhat to evaluate whether or not tonsillectomy 
would afford equivalent benefit to those children less severely affected 
than those in the previous trial. The study concludes that the limited 
benefit conferred by tonsillectomy in moderately affected children 
is outweighed by the risk, morbidity and cost of the surgery. In both 
studies, the mean number of days of sore throat in the 12 months 
following surgery was not statistically different between the operated 
and the non-operated group. Other studies reported that in children 
on waiting lists for adeno-/tonsillectomy, 18.6 - 50% of individuals no 
longer required surgery with a follow-up period of up to 3 years.[34-38] 
This points towards the understanding that there is a spontaneous 
reduction in rates of recurrent infection over time.
A 2006 literature review[39] suggested that adeno-/tonsillectomy, 
performed against a backdrop of SDB, demonstrated improvements in 
behaviour, neurocognitive function, quality of life and vocal quality. 
Similar studies have demonstrated improvement in physical and 
emotional symptoms, as well as daytime functioning.[40-42] In children 
with obstructive sleep apnoea (OSA), pulmonary hypertension was 
also shown to normalise on post-tonsillectomy echocardiography. 
Although most studies showed improvement in at least one outcome 
measure, these results are potentially misleading, as none of the studies 
was randomised. The CHAT trial (Childhood Adenotonsillectomy 
Trial)[43] published in 2013 was devised to address this shortcoming. 
A total of 464 children with obstructive sleep apnoea syndrome 
(OSAS), aged 5 - 9 years, were randomly assigned to either early 
adenotonsillectomy or watchful waiting. Outcome measures 
included general health, polysomnographic findings, behavioural 
and neurocognitive changes, assessed at baseline and 7 months 
after adenotonsillectomy. The study concluded that in children of 
school-going age with OSAS, surgery offered no improvement in 
attention or executive function. There was, however, improvement in 
behaviour, quality of life and polysomnographic findings following 
surgery, supporting early adenotonsillectomy in children with OSAS. 
This benefit was greater in obese children, although 33% of them 
had residual OSAS postoperatively. It should be noted that outcome 
measures showed improvement in the watchful waiting group too, 
but not to the same extent. Polysomnography, for example, improved 
in 79% of children undergoing surgery, and nearly half (46%) of the 
children in the watchful waiting group. With few adverse events, the 
CHAT trial supported the safety of both surgery and watchful waiting, 
but emphasised the importance of close monitoring of the watchful 
waiting group. Watchful waiting was deemed a valid therapeutic 
option.
In addition, tonsillar disease is often outgrown, the tonsils contribute 
to the protective functioning of the immune system, and adeno-/
tonsillectomy is a procedure associated with significant morbidity[44] 
and a mortality rate ranging from 1 in 16 000 to 1 in 35 000.[45] 
The risk and potential complications of adeno-/tonsillectomy are 
well documented and include the anaesthetic risk of laryngospasm, 
laryngeal oedema, aspiration, respiratory compromise, endotracheal 
tube ignition and cardiac arrest, as well as the intraoperative risk of 
blood loss, trauma to the teeth, tongue, pharynx, larynx and soft 
palate, lip, eye and mandible, and postoperative complications such as 
haemorrhage, delayed feeding and dehydration, nausea and vomiting, 
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pain and otalgia, post-obstructive pulmonary oedema, velopharyngeal 
insufficiency, voice changes and nasopharyngeal stenosis.[44,46] As 
such, the decision to offer patients an adeno-/tonsillectomy should 
not be a knee-jerk response, but a deliberated process, deemed to 
be in their best interests. Failure to meet the indications for adeno-/
tonsillectomy puts the patient at risk unnecessarily, with very little 
proven benefit.
5. Social, geographical and family factors
In the past, tonsillectomy was performed far more frequently in 
children of higher socioeconomic status. The social class association 
has, however, been reversed. According to the 2005 Chief Medical 
Officer’s Report (UK), tonsillectomy is now more common in children 
from less affluent backgrounds.[6] This is supported by the findings of 
international studies, which show that when access to healthcare 
is universally available, children of a lower socioeconomic status 
undergo tonsillectomy more frequently.[10,47] In their study in India to 
assess the bacteriology of acute tonsillitis, Vijayashree et al.[48] noted 
that 61% of cases came from a low-income group, 35% came from a 
middle-income group and only 4% came from a high-income group. 
The reasons cited for this preponderance of lower socioeconomic 
groups include poverty, malnutrition, unhygienic living conditions, 
illiteracy and poor access to healthcare. Like India, SA is a developing 
country, with an unemployment rate of 25% and a poverty level of 
56.8%.[19]  It is therefore possible that acute tonsillitis is encountered 
more frequently in children of a lower socioeconomic standing and 
that the burden of disease (frequency and/or severity) in SA is greater 
than in the developed world. This could account for the high SA 
adeno-/tonsillectomy rate, except that most patients making use of 
the private healthcare sector are of a high socioeconomic standing, 
comparable with the developed world. To the authors’ knowledge, no 
developing countries have reported an adeno-/tonsillectomy rate for 
comparison.
Physician-to-population ratio and patient proximity to a medical 
facility (geographical access barriers) have also been cited as potential 
factors contributing to variation in adeno-/tonsillectomy rates.[49] We 
found no such correlation in our study.
Tonsillectomy is often justified on the anecdotal opinion of parents 
whose children have undergone the procedure, claiming a dramatic 
improvement in their children’s general health and behaviour.[16,50] 
The perceived benefit of the procedure thus leads parents to request 
adeno-/tonsillectomy, as they believe surgery to be in the best 
interests of their children. These opinions are largely uninformed. 
However, parental preference or attempts at persuading doctors can 
interfere in the process of devising an appropriate management plan. 
Children with a parent or sibling who underwent tonsillectomy are 
also more likely to undergo the procedure.[11] The behavioural and 
cognitive effects of OSAS are particularly worrisome to parents. [51] 
As such, concerned parents might be more inclined to convince 
surgeons on the need for surgery. Often, parents’ desire for cure 
and complete resolution of symptoms drives their insistence. Most 
children experience a degree of improvement in their SDB following 
tonsillectomy, but only 60 - 70% of patients experience complete 
resolution of their symptoms. Only 10 - 25% of obese children 
experience resolution of their symptoms.[52] It is important for parents 
to be aware of this and not to harbour unrealistic expectations of 
improvement in symptoms. This might change parental attitudes 
towards surgery.
6. Private practice funding model dictating  
clinical practice
Fergusson and Horwood[53] report that privately insured children 
under 7 years of age are more likely to undergo adeno-/tonsillectomy 
than their uninsured counterparts. It is conceivable that parents 
paying a premium for healthcare might feel entitled to dictate the 
nature of the management of their children and request surgical 
intervention. Similarly, doctors being reimbursed by patients might 
feel compelled to accede to their requests. Whether or not this occurs 
and is reasonable practice is debatable and beyond the scope of this 
article. SA private health insurers do not enforce evidence-based 
selection of patients for tonsillectomy. As such, this is a system open 
to over-servicing of patients.
7. ‘Soft’ indications for adeno-/tonsillectomy
Relative indications for surgery include recurrent episodes of tonsillitis 
requiring hospitalisation, peritonsillar abscess, febrile seizures, 
orthodontic concerns or malocclusion, tonsilliths, halitosis, family 
history of rheumatic heart disease or glomerulonephritis, and tonsillar 
asymmetry (to exclude malignancy on histological specimen). The 
evidence supporting these indications is limited and of a lower quality 
than the evidence on which established guidelines are based. In such 
instances, shared decision-making is promoted. Factors such as the 
number of days of school missed by a child as a result of tonsillitis, 
tonsil size, the number of antibiotic courses completed and recurrent 
ear infections, are often used to justify tonsillectomy, but are not 
included in any of the guidelines.[26] The costs incurred as a result of 
frequent throat infections are substantial. These include the direct costs 
of consultation fees, transport and medication costs. Indirect costs 
include school and caregiver work absenteeism. Although cost and 
socioeconomic impact of disease are not included in the guidelines, 
the burden of disease is unequivocal, with an estimated 35 million 
days lost from school or work annually in the UK alone.[54] However, in 
the UK, the cost of managing a child with recurrent sore throats over 
a 2-year period equated to about a third of the cost of managing the 
patient surgically, with the modest benefit in the tonsillectomy group of 
3.5 episodes of sore throat fewer over the 2-year period.[5]
In summary, with so many additional considerations complicating 
the decision-making process, it seems the need for adeno-/
tonsillectomy is open to interpretation and determined by the 
significance attached to each of the abovementioned factors by the 
healthcare provider involved.
Study limitations
Retrospectively reviewing medical aid data, as an indication of clinical 
practice, rendered us reliant on data provided by medical schemes 
and our audit subject to patient selection bias. The tonsillectomy 
rate was described only in the private healthcare sector, presumably 
therefore among children of a higher socioeconomic status. The 
ethnicity of our patients has also not been reported, precluding an 
assessment of tonsillectomy trends in different ethnic groups.
We have described the tonsillectomy rate in approximately 
37% of the privately insured population (Discovery Health and 
Bonitas Medical Scheme), admittedly only a snapshot of the market. 
Collaboration between medical schemes would be required to report 
a more representative national private-sector tonsillectomy rate. 
It would also be interesting to determine the overall SA adeno-/
tonsillectomy rate, including the state sector, and to compare this 
rate with other developing countries. This would prove challenging, 
as no uniform reporting system or surgical registry in the SA state 
healthcare sector exists.
Indications for tonsillectomy are not recorded routinely by medical 
schemes and we cannot comment on the indications cited by surgeons 
to justify tonsillectomy in the SA private healthcare sector.
The authors believe that the findings of this study justify prospective 
analyses of tonsillectomy practice in the future. Assessing adherence 
to evidence-based guidelines and monitoring of tonsillectomy 
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indications and rates are potential future avenues for research. It is 
also hoped that other developing countries will be encouraged to 
publish tonsillectomy rates.
Conclusions
The SA tonsillectomy rate is very high compared with international 
trends and also varies regionally within the country. The literature 
does not support an increased burden of disease as the reason 
behind this. Rather, it is differences in training and clinical practice 
of clinicians, as well as social and family factors, that have been 
implicated. It is hoped that this article generates awareness among 
those managing children with recurrent sore throats and SDB around 
current best evidence-based practice. Whether consideration for 
adeno-/tonsillectomy should be protocol/check-sheet driven or if 
surgery should be offered at the attending surgeons’ discretion, is 
debatable. The authors, however, feel it would be a useful exercise 
to develop evidence-based, locally relevant indications for adeno-/
tonsillectomy to guide clinical practice in SA.
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